Regulators sooner or later stepped in. By 1984, the drug was shown as Schedule I from the US and also a Class B drug in the UK, that makes its generation and distribution illegal entirely.In contrast, identification of ligands targeting multidomain receptor complexes such given that the GABAARs or ionotropic glutamate receptors in a contest binding